在质母细胞瘤中BRAF突变的预后值
Ayesha Sohail1, Qurat-Ul-Ain Virani1, Hafiza Fatima Aziz1
1Section of Neurosurgery, Department of Surgery, Aga Khan University, Karachi, Pakistan.
JPMA. The Journal of the Pakistan Medical Association
|January 14, 2024
概括
在质母细胞瘤 (GBM) 中越来越多地发现了BRAF突变,特别是在异酸脱酶野生型GBM中. 本综述探讨了BRAF突变在GBM患者结局中的预后意义.
科学领域:
- 神经瘤学神经瘤学
- 分子遗传学 分子遗传学
- 癌症病理学 癌症病理学
背景情况:
- 质母细胞瘤 (GBM) 治疗正在与分子遗传学一起发展.
- 在各种脑瘤中发现了BRAF突变.
- 最近的发现突显了GBM中的BRAF突变,特别是IDH野生型GBM.
研究的目的:
- 审查质母细胞瘤中BRAF突变的预后价值.
- 了解BRAF突变在GBM患者结局中的作用.
主要方法:
- 对GBM中BRAF突变研究的文献综述.
- 对BRAF突变患病率和预后影响现有数据的分析.
主要成果:
- 在GBM患者的一小部分中存在BRAF突变.
- BRAF突变状态可能与IDH野生型GBM患者的结果相关.
结论:
- BRAF突变是GBM中一个相关的分子标记物.
- 需要进一步的研究,以充分阐明BRAF突变在GBM治疗策略中的预后作用.
相关概念视频
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


